The article discusses the COVID-19 vaccination program in Hong Kong, the unknowns and limitations of the three vaccines, and how the vaccination campaign should be launched. The authors emphasize the importance of transparency and respecting individual choices regarding the timing and type of vaccines. They also highlight the safety and efficacy of the vaccines in phase 3 clinical trials.